Michigan State University

Lysogene Licenses Gene Therapy Candidate From Yeda Research Advancing a collaboration inked in July 2020, gene therapy specialist Lysogene SA said on 12 April that it is taking its option to license

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bausch Makes $50m Commitment For Risute

Building on improvements in the price-performance of computing power and on early efforts to incorporate principles of physics in the modeling of ligand/receptor interactions, a few pioneering compani

IN VITRO DIAGNOSTICS CardioDx Inc. CardioDx sells $58mm of Series CC-1 and Series CC-2 preferred shares CardioDx Inc. (cardiovascular diagnostics) has raised $58mm through the sale of Series C